Login / Signup

Arpin deficiency increases actomyosin contractility and vascular permeability.

Armando Montoya-GarciaIdaira María Guerrero-FonsecaSandra D Chanez-ParedesKarina B Hernandez-AlmarazIliana I Leon-VegaAngelica Silva-OlivaresAbigail BetanzosMonica Mondragon-CastelanRicardo Mondragon-FloresCitlaltepetl Salinas-LaraHilda Vargas-RoblesMichael Schnoor
Published in: eLife (2024)
Arpin was discovered as an inhibitor of the Arp2/3 complex localized at the lamellipodial tip of fibroblasts, where it regulated migration steering. Recently, we showed that arpin stabilizes the epithelial barrier in an Arp2/3-dependent manner. However, the expression and functions of arpin in endothelial cells (EC) have not yet been described. Arpin mRNA and protein are expressed in EC and downregulated by pro-inflammatory cytokines. Arpin depletion in Human Umbilical Vein Endothelial Cells causes the formation of actomyosin stress fibers leading to increased permeability in an Arp2/3-independent manner. Instead, inhibitors of ROCK1 and ZIPK, kinases involved in the generation of stress fibers, normalize the loss-of-arpin effects on actin filaments and permeability. Arpin-deficient mice are viable but show a characteristic vascular phenotype in the lung including edema, microhemorrhage, and vascular congestion, increased F-actin levels, and vascular permeability. Our data show that, apart from being an Arp2/3 inhibitor, arpin is also a regulator of actomyosin contractility and endothelial barrier integrity.
Keyphrases
  • endothelial cells
  • poor prognosis
  • binding protein
  • vascular endothelial growth factor
  • electronic health record
  • long non coding rna
  • big data
  • deep learning
  • stress induced
  • small molecule
  • artificial intelligence